Institution
AstraZeneca (Poland)
Recent research
- Health & MedicineOpen access
Abstract Herein, we report a transition metal-free synthesis of monofluoroalkenes via a C–F bond reconstruction approach. The process employs inexpensive BF3·Et2O as a catalyst for the stereoselective intermolecular fluoroacylation of unactivated alkynes with alkyl/aryl acid fluo...
- Health & Medicine
Initial Changes in eGFR during Treatment with Balcinrenone and Dapagliflozin
Introduction: The novel non-steroidal mineralocorticoid receptor antagonist balcinrenone in combination with dapagliflozin reduced urinary albumin-to-creatinine ratio (UACR) over 12 weeks in the MIRO-CKD phase 2 trial in chronic kidney disease (CKD) and induced a modest acute eGF...
- BiologyOpen access
Abstract Background Evidence remains limited on disease journey for transthyretin (ATTR) amyloidosis in China. This study aims to analyse China data from OverTTuRe, an observational, retrospective, multi-country cohort study. Methods Data were extracted from medical records (2013...
- BiologyOpen access
Next‐Generation Manufacturing: The Evolving Role of Biocatalysis in AstraZeneca
Biocatalysis is becoming a strategic manufacturing capability at AstraZeneca, enabling selective transformations under milder conditions and with the potential to reduce waste and resource intensity relative to conventional routes. This review summarizes how AstraZeneca is embedd...
- Health & Medicine
Tozorakimab to Prevent COPD Exacerbations
BACKGROUND: Many patients with chronic obstructive pulmonary disease (COPD) have exacerbations despite receiving standard-of-care inhaled maintenance therapy. Dysregulated interleukin-33 signaling is implicated in the pathogenesis of COPD. Tozorakimab is a monoclonal antibody tha...
- Health & MedicineOpen access
The rapid evolution of SARS-CoV-2 has necessitated efforts to accelerate the clinical evaluation of neutralizing monoclonal antibodies. Little DIPPER and the SUPERNOVA substudy explored the feasibility of immunobridging efficacy from tixagevimab–cilgavimab to sipavibart using pre...
- AI & ComputingOpen access
Leveraging Synthetic Clinical Data for Validation and Operational Readiness in Clinical Trials
Background/Objectives: Obtaining timely access to detailed clinical trial data is not always straightforward. Privacy requirements, governance processes, and study-specific eCRF configurations can delay access, particularly during study start-up, when teams need realistic data to...
- Health & MedicineOpen access
Both inactivated influenza vaccine and live attenuated influenza vaccine (LAIV) (indicated for use in children aged 2–17 years) effectively prevent influenza transmission and related outcomes. Despite high transmission among children, vaccination practices in Sweden focus primari...
- Health & MedicineOpen access
Clinical trials report no increased malignancy risk with benralizumab in severe asthma; however, trial populations are highly selective. To better define real-world safety, malignancy risk was compared among patients treated with benralizumab, other (non-benralizumab) biologics,...
- Materials & EnergyOpen access
Abstract Deep eutectic solvents (DESs) are emerging sustainable alternatives to traditional organic solvents, yet their influence on chemical reactivity remains underexplored. Here, we investigate the oxidation of aldehydes to carboxylic acids using diluted hydrogen peroxide in a...